<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T10:56:42Z</responseDate>
  <request identifier="oai:figshare.com:article/33966689" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33966689</identifier>
        <datestamp>2026-09-22T17:22:49Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Subgroup analyses for the associations of discordant metabolic phenotypes with the risk of hyperuricemia.&lt;/p&gt;</dc:title>
          <dc:creator>Lusha Li (25091078)</dc:creator>
          <dc:creator>Jingkai Yan (11409269)</dc:creator>
          <dc:creator>Xixuan Cai (25091081)</dc:creator>
          <dc:creator>Jianjiang Pan (25091084)</dc:creator>
          <dc:creator>Liying Chen (4223026)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>spline curves revealed</dc:subject>
          <dc:subject>significant synergistic effect</dc:subject>
          <dc:subject>significant multiplicative interaction</dc:subject>
          <dc:subject>restricted cubic splines</dc:subject>
          <dc:subject>rapid lifestyle transitions</dc:subject>
          <dc:subject>multivariable logistic regression</dc:subject>
          <dc:subject>lipid accumulation product</dc:subject>
          <dc:subject>isolated glycemic control</dc:subject>
          <dc:subject>inherent estrogenic urate</dc:subject>
          <dc:subject>&amp;# 178 ;.</dc:subject>
          <dc:subject>assess risk stratifications</dc:subject>
          <dc:subject>december 2025 ).</dc:subject>
          <dc:subject>among discordant phenotypes</dc:subject>
          <dc:subject>principal metabolic correlate</dc:subject>
          <dc:subject>xlink "&gt; driven</dc:subject>
          <dc:subject>evaluate synergistic effects</dc:subject>
          <dc:subject>pronounced relative risk</dc:subject>
          <dc:subject>isolated high tyg</dc:subject>
          <dc:subject>023 ), double</dc:subject>
          <dc:subject>tyg exhibited independent</dc:subject>
          <dc:subject>xlink "&gt; lap</dc:subject>
          <dc:subject>high hua risk</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>relative dominance</dc:subject>
          <dc:subject>particularly pronounced</dc:subject>
          <dc:subject>discordant associations</dc:subject>
          <dc:subject>259 ).</dc:subject>
          <dc:subject>236 ),</dc:subject>
          <dc:subject>metabolic burden</dc:subject>
          <dc:subject>dual metabolic</dc:subject>
          <dc:subject>hua risk</dc:subject>
          <dc:subject>tyg attenuation</dc:subject>
          <dc:subject>visceral fat</dc:subject>
          <dc:subject>visceral adiposity</dc:subject>
          <dc:subject>uricosuric benefits</dc:subject>
          <dc:subject>subgroup analyses</dc:subject>
          <dc:subject>striking dominance</dc:subject>
          <dc:subject>response relationships</dc:subject>
          <dc:subject>paradoxical decline</dc:subject>
          <dc:subject>linear dose</dc:subject>
          <dc:subject>insulin resistance</dc:subject>
          <dc:subject>findings suggest</dc:subject>
          <dc:subject>concurrent structural</dc:subject>
          <dc:subject>clinical importance</dc:subject>
          <dc:subject>attributable proportion</dc:subject>
          <dc:subject>additive scale</dc:subject>
          <dc:description>&lt;p&gt;Subgroup analyses for the associations of discordant metabolic phenotypes with the risk of hyperuricemia.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T17:22:43Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0357105.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Subgroup_analyses_for_the_associations_of_discordant_metabolic_phenotypes_with_the_risk_of_hyperuricemia_p_/33966689</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
